CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic
Epitope
Cytotoxic CD8+ T cells (CTLs) play a critical role in controlling viral
infections. HIV-infected individuals develop CTL responses against epitopes
derived from viral proteins, but also against cryptic epitopes encoded by viral
alternative reading frames (ARF). We studied here the mechanisms of HIV-1 escape
from CTLs targeting one such cryptic epitope, Q9VF, encoded by an
HIVgag ARF and presented by HLA-B*07. Using PBMCs of
HIV-infected patients, we first cloned and sequenced proviral DNA encoding for
Q9VF. We identified several polymorphisms with a minority of proviruses encoding
at position 5 an aspartic acid (Q9VF/5D) and a majority encoding an asparagine
(Q9VF/5N). We compared the prevalence of each variant in PBMCs of
HLA-B*07+ and HLA-B*07- patients. Proviruses encoding Q9VF/5D were
significantly less represented in HLA-B*07+ than in HLA-B*07-
patients, suggesting that Q9FV/5D encoding viruses might be under selective
pressure in HLA-B*07+ individuals. We thus analyzed ex
vivo CTL responses directed against Q9VF/5D and Q9VF/5N. Around
16% of HLA-B*07+ patients exhibited CTL responses targeting Q9VF
epitopes. The frequency and the magnitude of CTL responses induced with Q9VF/5D
or Q9VF/5N peptides were almost equal indicating a possible cross-reactivity of
the same CTLs on the two peptides. We then dissected the cellular mechanisms
involved in the presentation of Q9VF variants. As expected, cells infected with
HIV strains encoding for Q9VF/5D were recognized by Q9VF/5D-specific CTLs. In
contrast, Q9VF/5N-encoding strains were neither recognized by Q9VF/5N- nor by
Q9VF/5D-specific CTLs. Using in vitro proteasomal digestions
and MS/MS analysis, we demonstrate that the 5N variation introduces a strong
proteasomal cleavage site within the epitope, leading to a dramatic reduction of
Q9VF epitope production. Our results strongly suggest that HIV-1 escapes CTL
surveillance by introducing mutations leading to HIV ARF-epitope destruction by
proteasomes.
Vyšlo v časopise:
CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic
Epitope. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1002049
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002049
Souhrn
Cytotoxic CD8+ T cells (CTLs) play a critical role in controlling viral
infections. HIV-infected individuals develop CTL responses against epitopes
derived from viral proteins, but also against cryptic epitopes encoded by viral
alternative reading frames (ARF). We studied here the mechanisms of HIV-1 escape
from CTLs targeting one such cryptic epitope, Q9VF, encoded by an
HIVgag ARF and presented by HLA-B*07. Using PBMCs of
HIV-infected patients, we first cloned and sequenced proviral DNA encoding for
Q9VF. We identified several polymorphisms with a minority of proviruses encoding
at position 5 an aspartic acid (Q9VF/5D) and a majority encoding an asparagine
(Q9VF/5N). We compared the prevalence of each variant in PBMCs of
HLA-B*07+ and HLA-B*07- patients. Proviruses encoding Q9VF/5D were
significantly less represented in HLA-B*07+ than in HLA-B*07-
patients, suggesting that Q9FV/5D encoding viruses might be under selective
pressure in HLA-B*07+ individuals. We thus analyzed ex
vivo CTL responses directed against Q9VF/5D and Q9VF/5N. Around
16% of HLA-B*07+ patients exhibited CTL responses targeting Q9VF
epitopes. The frequency and the magnitude of CTL responses induced with Q9VF/5D
or Q9VF/5N peptides were almost equal indicating a possible cross-reactivity of
the same CTLs on the two peptides. We then dissected the cellular mechanisms
involved in the presentation of Q9VF variants. As expected, cells infected with
HIV strains encoding for Q9VF/5D were recognized by Q9VF/5D-specific CTLs. In
contrast, Q9VF/5N-encoding strains were neither recognized by Q9VF/5N- nor by
Q9VF/5D-specific CTLs. Using in vitro proteasomal digestions
and MS/MS analysis, we demonstrate that the 5N variation introduces a strong
proteasomal cleavage site within the epitope, leading to a dramatic reduction of
Q9VF epitope production. Our results strongly suggest that HIV-1 escapes CTL
surveillance by introducing mutations leading to HIV ARF-epitope destruction by
proteasomes.
Zdroje
1. WangYELiBCarlsonJMStreeckHGladdenAD
2009
Protective HLA class I alleles that restrict acute-phase
CD8+ T-cell responses are associated with viral escape mutations
located in highly conserved regions of human immunodeficiency virus type
1.
J Virol
83
1845
1855
2. GoonetillekeNLiuMKSalazar-GonzalezJFFerrariGGiorgiE
2009
The first T cell response to transmitted/founder virus
contributes to the control of acute viremia in HIV-1
infection.
J Exp Med
206
1253
1272
3. KoupRASafritJTCaoYAndrewsCALeodGM
1994
Temporal association of cellular immune responses with the
initial control of viremia in primary human immunodeficiency virus type 1
syndrome.
J Virol
68
4650
4655
4. KiepielaPLeslieAJHoneyborneIRamduthDThobakgaleC
2004
Dominant influence of HLA-B in mediating the potential
co-evolution of HIV and HLA.
Nature
432
769
775
5. KiepielaPNgumbelaKThobakgaleCRamduthDHoneyborneI
2007
CD8+ T-cell responses to different HIV proteins have
discordant associations with viral load.
Nat Med
13
46
53
6. BrummeZLJohnMCarlsonJMBrummeCJChanD
2009
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol
and Nef proteins.
PLoS One
4
e6687
7. DudaALee-TurnerLFoxJRobinsonNDustanS
2009
HLA-associated clinical progression correlates with epitope
reversion rates in early human immunodeficiency virus
infection.
J Virol
83
1228
1239
8. GoulderPJBranderCTangYTremblayCColbertRA
2001
Evolution and transmission of stable CTL escape mutations in HIV
infection.
Nature
412
334
338
9. KawashimaYPfafferottKFraterJMatthewsPPayneR
2009
Adaptation of HIV-1 to human leukocyte antigen class
I.
Nature
458
641
645
10. KoizumiHHashimotoMFujiwaraMMurakoshiHChikataT
2010
Different in vivo effects of HIV-1 immunodominant
epitope-specific CTLs on selection of escape mutant viruses.
J Virol
84
5508
19
11. PhilipsRERowland-JonesSNixonDFGotchFMEdwardsJP
1991
Human immunodeficiency virus genetic variation that can escape
cytotoxic T cell recognition.
Nature
354
453
459
12. BorrowPLewickiHWeiXHorwitzMSPefferN
1997
Antiviral pressure exerted by HIV-1-specific cytotoxic T
lymphocytes (CTLs) during primary infection demonstrated by rapid selection
of CTL escape virus.
Nat Med
3
205
211
13. GoulderPJPhillipsREColbertRAMcAdamSOggG
1997
Late escape from an immunodominant cytotoxic T-lymphocyte
response associated with progression to AIDS.
Nat Med
3
212
217
14. GoulderPJWatkinsDI
2004
HIV and SIV CTL escape: implications for vaccine
design.
Nat Rev Immunol
4
630
640
15. TenzerSWeeEBurgevinAStewart-JonesGFriisL
2009
Antigen processing influences HIV-specific cytotoxic T lymphocyte
immunodominance.
Nat Immunol
10
636
646
16. DraenertRLe GallSPfafferottKJLeslieAJChettyP
2004
Immune selection for altered antigen processing leads to
cytotoxic T lymphocyte escape in chronic HIV-1 infection.
J Exp Med
199
905
915
17. Le GallSStamegnaPWalkerBD
2007
Portable flanking sequences modulate CTL epitope
processing.
J Clin Invest
117
3563
3575
18. MilicicAPriceDAZimbwaPBoothBLBrownHL
2005
CD8+ T cell epitope-flanking mutations disrupt proteasomal
processing of HIV-1 Nef.
J Immunol
175
4618
4626
19. ZimbwaPMilicicAFraterJScribaTJWillisA
2007
Precise identification of a human immunodeficiency virus type 1
antigen processing mutant.
J Virol
81
2031
2038
20. YokomakuYMiuraHTomiyamaHKawana-TachikawaATakiguchiM
2004
Impaired processing and presentation of cytotoxic-T-lymphocyte
(CTL) epitopes are major escape mechanisms from CTL immune pressure in human
immunodeficiency virus type 1 infection.
J Virol
78
1324
1332
21. SchubertUAntonLCGibbsJNorburyCCYewdellJW
2000
Rapid degradation of a large fraction of newly synthesized
proteins by proteasomes.
Nature
404
770
774
22. CasartelliNGuivel-BenhassineFBouziatRBrandlerSSchwartzO
2010
The antiviral factor APOBEC3G improves CTL recognition of
cultured HIV-infected T cells.
J Exp Med
207
39
49
23. CardinaudSStarckSRChandraPShastriN
2010
The synthesis of truncated polypeptides for immune surveillance
and viral evasion.
PLoS One
5
e8692
24. CardinaudSBouziatRRohrlichPSTourdotSWeissL
2009
Design of a HIV-1-derived HLA-B07.02-restricted polyepitope
construct.
Aids
23
1945
1954
25. HoOGreenWR
2006
Alternative translational products and cryptic T cell epitopes:
expecting the unexpected.
J Immunol
177
8283
8289
26. SaulquinXScotetETrautmannLPeyratMAHalaryF
2002
+1 Frameshifting as a novel mechanism to generate a cryptic
cytotoxic T lymphocyte epitope derived from human interleukin
10.
J Exp Med
195
353
358
27. WangRFParkhurstMRKawakamiYRobbinsPFRosenbergSA
1996
Utilization of an alternative open reading frame of a normal gene
in generating a novel human cancer antigen.
J Exp Med
183
1131
1140
28. GodetYMoreau-AubryAGuillouxYVignardVKhammariA
2008
MELOE-1 is a new antigen overexpressed in melanomas and involved
in adoptive T cell transfer efficiency.
J Exp Med
205
2673
2682
29. BullockTNEisenlohrLC
1996
Ribosomal scanning past the primary initiation codon as a
mechanism for expression of CTL epitopes encoded in alternative reading
frames.
J Exp Med
184
1319
1329
30. MayrandSMSchwarzDAGreenWR
1998
An alternative translational reading frame encodes an
immunodominant retroviral CTL determinant expressed by an
immunodeficiency-causing retrovirus.
J Immunol
160
39
50
31. ManessNJValentineLEMayGEReedJPiaskowskiSM
2007
AIDS virus specific CD8+ T lymphocytes against an
immunodominant cryptic epitope select for viral escape.
J Exp Med
204
2505
2512
32. CardinaudSMorisAFevrierMRohrlichPSWeissL
2004
Identification of cryptic MHC I-restricted epitopes encoded by
HIV-1 alternative reading frames.
J Exp Med
199
1053
1063
33. BansalACarlsonJYanJAkinsikuOTSchaeferM
2010
CD8 T cell response and evolutionary pressure to HIV-1 cryptic
epitopes derived from antisense transcription.
J Exp Med 207: 51-59,
S51-53
34. BergerCTCarlsonJMBrummeCJHartmanKLBrummeZL
2010
Viral adaptation to immune selection pressure by HLA class
I-restricted CTL responses targeting epitopes in HIV frameshift
sequences.
J Exp Med 207: 61-75,
S61-12
35. SchweighardtBWrinTMeiklejohnDASpottsGPetropoulosCJ
2010
Immune escape mutations detected within HIV-1 epitopes associated
with viral control during treatment interruption.
J Acquir Immune Defic Syndr
53
36
46
36. GarrisonKEChampiatSYorkVAAgrawalATKallasEG
2009
Transcriptional errors in human immunodeficiency virus type 1
generate targets for T-cell responses.
Clin Vaccine Immunol
16
1369
1371
37. RohrlichPSCardinaudSFiratHLamariMBriandP
2003
HLA-B*0702 transgenic, H-2K(b)D(b) double-knockout mice:
phenotypical and functional characterization in response to influenza
virus.
Int Immunol
15
765
772
38. KloetzelPM
2001
Antigen processing by the proteasome.
Nat Rev Mol Cell Biol
2
179
187
39. FalkKRotzschkeOStevanovicSJungGRammenseeHG
1991
Allele-specific motifs revealed by sequencing of self-peptides
eluted from MHC molecules.
Nature
351
290
296
40. RammenseeHBachmannJEmmerichNPBachorOAStevanovicS
1999
SYFPEITHI: database for MHC ligands and peptide
motifs.
Immunogenetics
50
213
219
41. LauvauGKakimiKNiedermannGOstankovitchMYotndaP
1999
Human transporters associated with antigen processing (TAPs)
select epitope precursor peptides for processing in the endoplasmic
reticulum and presentation to T cells.
J Exp Med
190
1227
1240
42. SerwoldTGawSShastriN
2001
ER aminopeptidases generate a unique pool of peptides for MHC
class I molecules.
Nat Immunol
2
644
651
43. SaricTBeningaJGraefCIAkopianTNRockKL
2001
Major histocompatibility complex class I-presented antigenic
peptides are degraded in cytosolic extracts primarily by thimet
oligopeptidase.
J Biol Chem
276
36474
36481
44. van EndertPMRiganelliDGrecoGFleischhauerKSidneyJ
1995
The peptide-binding motif for the human transporter associated
with antigen processing.
J Exp Med
182
1883
1895
45. CascioPHiltonCKisselevAFRockKLGoldbergAL
2001
26S proteasomes and immunoproteasomes produce mainly N-extended
versions of an antigenic peptide.
Embo J
20
2357
2366
46. MorisANobileCBuseyneFPorrotFAbastadoJP
2004
DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen
presentation.
Blood
103
2648
2654
47. OssendorpFEggersMNeisigARuppertTGroettrupM
1996
A single residue exchange within a viral CTL epitope alters
proteasome-mediated degradation resulting in lack of antigen
presentation.
Immunity
5
115
124
48. ChapiroJClaverolSPietteFMaWStroobantV
2006
Destructive cleavage of antigenic peptides either by the
immunoproteasome or by the standard proteasome results in differential
antigen presentation.
J Immunol
176
1053
1061
49. GavioliRGalleraniEFortiniCFabrisMBottoniA
2004
HIV-1 tat protein modulates the generation of cytotoxic T cell
epitopes by modifying proteasome composition and enzymatic
activity.
J Immunol
173
3838
3843
50. ToesRENussbaumAKDegermannSSchirleMEmmerichNP
2001
Discrete cleavage motifs of constitutive and immunoproteasomes
revealed by quantitative analysis of cleavage products.
J Exp Med
194
1
12
51. KuckelkornUFerreiraEADrungILiewerUKloetzelPM
2002
The effect of the interferon-gamma-inducible processing machinery
on the generation of a naturally tumor-associated human cytotoxic T
lymphocyte epitope within a wild-type and mutant p53 sequence
context.
Eur J Immunol
32
1368
1375
52. SchwabSRLiKCKangCShastriN
2003
Constitutive display of cryptic translation products by MHC class
I molecules.
Science
301
1367
1371
53. WattsJMDangKKGorelickRJLeonardCWBessJWJr
2009
Architecture and secondary structure of an entire HIV-1 RNA
genome.
Nature
460
711
716
54. AllenTMAltfeldMGeerSCKalifeETMooreC
2005
Selective escape from CD8+ T-cell responses represents a
major driving force of human immunodeficiency virus type 1 (HIV-1) sequence
diversity and reveals constraints on HIV-1 evolution.
J Virol
79
13239
13249
55. ParcejDTampeR
2010
ABC proteins in antigen translocation and viral
inhibition.
Nat Chem Biol
6
572
580
56. BaslerMYouhnovskiNVan Den BroekMPrzybylskiMGroettrupM
2004
Immunoproteasomes down-regulate presentation of a subdominant T
cell epitope from lymphocytic choriomeningitis virus.
J Immunol
173
3925
3934
57. AlmeidaJRPriceDAPapagnoLArkoubZASauceD
2007
Superior control of HIV-1 replication by CD8+ T cells is
reflected by their avidity, polyfunctionality, and clonal
turnover.
J Exp Med
204
2473
2485
58. ManessNJWilsonNAReedJSPiaskowskiSMSachaJB
2010
Robust, vaccine-induced CD8(+) T lymphocyte response against
an out-of-frame epitope.
J Immunol
184
67
72
59. MartinezVCostagliolaDBonduelleON'goNSchnurigerA
2005
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2
antibodies is the best predictor for persistence of long-term
nonprogression.
J Infect Dis
191
2053
2063
60. BunceMO'NeillCMBarnardoMCKrausaPBrowningMJ
1995
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1,
DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing
sequence-specific primers (PCR-SSP).
Tissue Antigens
46
355
367
61. DunbarSA
2006
Applications of Luminex xMAP technology for rapid,
high-throughput multiplexed nucleic acid detection.
Clin Chim Acta
363
71
82
62. MorisAPajotABlanchetFGuivel-BenhassineFSalcedoM
2006
Dendritic cells and HIV-specific CD4+ T cells: HIV antigen
presentation, T-cell activation, and viral transfer.
Blood
108
1643
1651
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 5
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex
- The OXI1 Kinase Pathway Mediates -Induced Growth Promotion in Arabidopsis
- The Hexamer Structure of the Rift Valley Fever Virus Nucleoprotein Suggests a Mechanism for its Assembly into Ribonucleoprotein Complexes
- Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt